Curaleaf Holdings (CURLF) Net Equity Issued and Repurchased (2021)
Curaleaf Holdings (CURLF) posted quarterly Net Equity Issued and Repurchased of -$3000.0 for Q4 2021, down 200.0% on a QoQ basis from $3000.0 in Q3 2021.
Curaleaf Holdings (CURLF) Net Equity Issued and Repurchased (2021) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Net Equity Issued and Repurchased for 1 consecutive years, with -$3000.0 the latest figure, recorded in Q4 2021.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$3000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $240.6 million (changed N/A YoY) and the FY2023 annual result came in at $11.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased fell to -$3000.0 in Q4 2021 per CURLF's latest filing, from $3000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for CURLF reached as high as $240.6 million in Q1 2021 and fell as low as -$3000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -3,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 240.57 Mn |
| Mar 31, 2021 | 240.57 Mn |